Mechanical Circulatory Support Symposium 2018

Preliminary Program Agenda
Day 1: Thursday, March 8, 2018

8:00 AM

Welcome and Opening Remarks
Jeffrey A. Morgan, Texas Heart Institute, Baylor College of Medicine

Session I: Patient Selection and Optimization for Long-Term MCS Devices
Moderated by: Jeffrey A. Morgan, Texas Heart Institute, Baylor College of Medicine 
                           Joseph Rogers,  Duke University

8:20 AM

Choosing the Optimal Candidate for Long-Term MCS
Paolo C. Colombo, Columbia Presbyterian Medical Center

8:40 AM

Predicting Outcomes in LVAD Recipients

9:00 AM

What has INTERMACS Taught Us About Patient Outcomes with Durable MCS?
James K. Kirklin, University of Alabama at Birmingham

9:20 AM

Results Using Implantable MCS Devices In Patients with Acute Cardiogenic Shock: Should We Rethink the Paradigm?
Michael A. Acker, University of Pennsylvania

9:40 AM

Panel Discussion

Session II: Controversial Topics With Long-Term Device Therapy
Moderated by: Mark S. Slaughter, University of Louisville, Jewish Hospital

10:20 AM

Recent Trials With Long-Term LVADs: Is There a Superior Device?
Francis Dr. Pagani, Michigan Medicine, University of Michigan

10:40 AM

Results of Long-Term Durable LVAD Therapy Is Improving: Implications for Transplant Listing

11:00 AM

Is 70 Years Too Old for a VAD?
Jeffrey A. Morgan, Texas Heart Institute, Baylor College of Medicine

11:20 AM

Recovery with Durable LVADs Is Underutilized
Nir Uriel, University of Chicago Medicine

 11:40 AM Panel Discussion
 12:00 PM Lunch

Session III: Lifetime Recognition Award in MCS and Keynote Lecture

1:30 PM

Dr. O.H. "Bud" Frazier to Receive Lifetime Achievement Award in MCS
Introduction by Robert C. Robbins, Texas Medical Center

1:45 PM

Keynote Lecture: Overcoming the Limitations of Long-Term MCS Devices
Mark S. Slaughter, University of Louisville, Jewish Hospital

CONCURRENT
Session IV: Bridge Strategies With Short-Term Devices
Moderated by: Francis D. Pagani, Michigan Medical, University of Michigan

2:15 PM 

Timing the Transition from Short to Long-Term MCS or Transplant
Andrew Civitello, Texas Heart Institute, Baylor College of Medicine

2:30 PM 

Bridging with Percutaneous Devices - Tandem Heart and Impella
David Baran, Newark Beth Israel Medical Center

2:45 PM

ECMO as a Bridge to Long-Term LVAD Therapy
Jonathan W. Haft, University of Michigan

3:00 PM 

Surgical Strategies for Temporary MCS
Michael A. Acker, University of Pennsylvania

3:15 PM

Panel Discussion

CONCURRENT
Session V: The Role of ECLS in Lung Transplantation

2:15 PM

Optimizing the Donor Lung with EVLP

2:30 PM

ECLS Bridge to Lung Transplant - Optimizing and Ambulating the Recipient

2:45 PM Optimal Intra-op Support (Pump vs No Pump, CPB vs ECMO)
3:00 PM Optimal Intraop Cannula Configuration - Managing the Pre-Cannulated Patient
3:15 PM Preventing/Managing (Severe) PGD

 
 
 
 
 
 
 
 

Preliminary Program Agenda
Day 2: Friday, March 9, 2018

Session VI: MCS Device Thrombosis
Moderated by: Jeffrey A. Morgan, Texas Heart Institute, Baylor College of Medicine
8:00 AM Diagnosis of Device Thrombosis                                                                                                                                         
8:20 AM Medical Management of Device Thrombosis
Sean P. Pinney, Mount Sinai Health Systems
8:40 AM Are the Results for Device Exchange Improving? Technique and Outcomes for Device Exchange
Ranjit John, University of Minnesota
9:00 AM MOMENTUM and ENDURANCE - What Do These Trials Tell Us About Pump Thrombosis
Simon Maltais, Mayo Clinic
9:20 AM Panel Discussion
Session VII: Debates on Controversial Subjects
Moderated by: Francis D. Pagani, Michigan Medicine, University of Michigan
                           Paolo Colombo, Columbia Presbyterian Medical Center
10:10 AM Class III Patients Should Undergo LVAD Implantations
Pro: Ajith Nair, Texas Heart Institute, Baylor College of Medicine
Con: Sean P. Pinney, Mount Sinai Health System
10:20 AM Moderate TR Should Be Repaired at the Time of LVAD
Pro: Robert Kormos, University of Pittsburgh, Presbyterian University Hospital
Con: James K. Kirklin, University of Alabama at Birmingham
10:40 AM Results with TAH are Superior to BiVAD in Patients With Severe RV Dysfunction? 
Pro: Jeffrey A. Morgan, Texas Heart Institute, Baylor College of Medicine
Con: Ranjit John, University of Minnesota
11:00 AM Panel Discussion
Session VIII:
11:15 AM Stem Cells, Gene Therapy, and Cellular Reprogramming as Adjunctive Therapies for LVAD Recipients and a Bridge to Recovery
12:00 PM Lunch
CONCURRENT
Session IX: Minimally Invasive LVAD Insertion, Concomitant Procedures

Moderated by: Mark S. Slaughter, University of Louisville, Jewish Hospital
                           
Sean P. Pinney, Mount Sinai Health Systems
1:30 PM Minimally Invasive Insertion of HVAD
Simon Maltais, Mayo Clinic
1:45 PM Off-Pump LVAD Insertions: Pros and Cons
Michael A. Acker, University of Pennsylvania
2:00 PM Should Severe Mitral Regurgitation Be Addressed at LVAD Implant?
Jonathan W. Haft, University of Michigan
2:15 PM Indications for Intervention and Surgical Techniques to Manage Aortic Insufficiency at LVAD Impant
Robert L. Kormos, Universty of Pittsburgh, Presbyterian University Hospital
2:30 PM Panel Discussion
CONCURRENT
Session X: ECMO for Respiratory Failure

1:30 PM
Setting up an ECLS Program
1:45 PM Indications/Contradictions for ECLS in Respiratory Failure
2:00 PM
How to Select Best Cannulation Configuration (VA, VVA, VV with 1 or 2 Cannulae)
2:15 PM
Anticoagulation Strategies: Routine, Bleeding and Heparin Resistant Patient
2:30 PM
Weaning from ECLS: When and How? 
CONCURRENT
Session XI: Complications Using Long-Term MCS

Moderated by: Jonathan W. Haft, University of Michigan
3:15 PM Gastrointerestinal Bleeding: Diagnosis and Management Strategies
Paolo C. Columbo, Columbia Presbyterian Medical Center
3:30 PM Stroke: Medical and Surgical Approaches to Prevention
Ranjit John, University of Minnesota
3:45 PM Aortic Insufficiency: How Often Does It Occur and When To Treat
Simon Maltais, Mayo Clinic
4:00 PM Recognition and Treatment of Right Ventricular Failure
Robery L. Kormos, University of Pittsburgh, Presbyterian University Hospital
4:15 PM Panel Discussion
CONCURRENT
Session XII: ECMo for Respiratory Failure - Pushing the Boundaries

3:30 PM
Cross Circulation ECMO for Organ Recovery, Biohybrid Lung and New Devices
3:45 PM
ECMO Transport (Air and Ground): Who to Cannulate in the Field
4:00 PM
eCPR: How Far is Too Far?
4:15 PM Panel Discussion
   
 *Program Subject to Change

 

 W. Randolph Chitwood, Jr & Pedro J. del Nido
 W. Randolph Chitwood, Jr & Pedro J. del Nido


MCS18 Preliminary Program
(Adobe PDF File)